In vivo T-cell depletion with low-dose alemtuzumab in non myeloablative allogeneic transplants is associated with a relatively rapid immunereconstitution and reduced incidence of graft-versus-host disease / Dodero, A; Milani, R; Carrabba, M; Rizzo, E; Milanesi, M; Longoni, P; Montefusco, V; Farina, L; Lucesole, M; Leoni, Pietro; Olivieri, Attilio; Corradini, P.. - In: BLOOD. - ISSN 0006-4971. - (2003).
In vivo T-cell depletion with low-dose alemtuzumab in non myeloablative allogeneic transplants is associated with a relatively rapid immunereconstitution and reduced incidence of graft-versus-host disease.
LEONI, Pietro;OLIVIERI, Attilio;
2003-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
